CNXCConcentrix Corporation

$25.95-53% 1Y

Is the business good?

Mixed

The checks split: nothing decisive, though margins compressing.

1 to watch, 1 neutral, 2 without data
Fundamental health (F-score)4 / 9SEC EDGAR · Nov 30, 2025

Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.

Margin direction, 3 years−20.0 ptsderived

Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is CNXC?

Concentrix Corporation earns −11% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

−11%

Return on invested capital · cost of capital 9.0% · 20 points below what the capital costs: growth destroys value

Operating margin
−10%

Operating margin · Information Technology Services median 8.0% · 12 months to Q2 2026

Share count, year on year
−4.0%

Share count, year on year · bought back, each share owns more of the company

Gross margin
34%

Gross margin

Operating margin by fiscal year
YearOperating margin
FY20206.5%
FY202110%
FY202210%
FY20239.3%
FY20246.2%
FY2025−9.3%
Details›
Gross margin12 months to Q2 2026
34%
Operating margin12 months to Q2 2026
−10%
Net margin12 months to Q2 2026
−13%
Free cash flow margin
5.1%
Revenue, trailing twelve months
$10.00B
Free cash flow, trailing twelve months
$514M
Net income, trailing twelve months
−$1.31B
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
−11%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

On our screens:Most shorted stocks